A Point-of-Care LNP Formulation for Rapid Manufacturing of Personalized Cancer Vaccines

• Showcasing an off‑the‑shelf lipid nanoparticle platform, eliminating the need for bespoke formulation development
• Personalized vaccines are rapidly manufactured by simply incorporating patient‑specific mRNAs
• This modular approach dramatically shortens manufacturing timelines and significantly lowers production costs for personalized cancer vaccines

Speakers:

Raejsh Krishnan

VP

Providence Therapeutics